PNI (albumin + lymphocyte count) was originally used to assess nutritional status in gastric cancer (27) and has since been applied to cervical cancer (28), diabetic nephropathy (29), and cognitive decline in the elderly (30). The gene discussed is ALB; the disease is diabetic kidney disease.